Association between smoking and obstructive sleep apnea based on the STOP-Bang index
In late 2023, the FDA added more than a dozen peptides including both BPC-157 and thymosin alpha 1 to its list of substances that should not be compounded because the agency has identified potential significant safety risks. For BPC-157, the agency warned that the peptide could trigger an immune response
The BMI criteria presented in this statement align with the current Medicare Benefits Schedule criteria for metabolic bariatric surgery
The reaction mixture was stirred at RT for 16 h to allow complete functionalization
In fact, GLP-1 Treatments, Semaglutide or Tirzepatide is widely recognized as an effective, FDA-approved option in the realm of anti-obesity medications
Liyun He, from the Peking Union Medical College Hospital in China, and colleagues conducted a systematic review of randomized controlled trials (RCTs) comparing the use of GLP-1 RA drugs with placebo or with non-GLP-1 RA drugs in adults to examine the association with gallbladder and biliary diseases